TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $874,000 | -91.2% | 39,577 | -87.7% | 0.01% | -88.6% |
| Q4 2020 | $9,987,000 | +52.2% | 322,903 | 0.0% | 0.08% | +58.0% |
| Q3 2020 | $6,561,000 | +32.3% | 322,903 | 0.0% | 0.05% | +11.1% |
| Q2 2020 | $4,960,000 | +98.5% | 322,903 | 0.0% | 0.04% | +32.4% |
| Q1 2020 | $2,499,000 | -45.8% | 322,903 | 0.0% | 0.03% | -40.4% |
| Q4 2019 | $4,611,000 | -5.0% | 322,903 | 0.0% | 0.06% | -14.9% |
| Q3 2019 | $4,853,000 | – | 322,903 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |